Chowdhury Lab News

Study Finds Source of PARP Inhibitor Drug Resistance

Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas

Katherine Choe awarded American Cancer Society Postdoctoral Fellowship

Inside the Institute spotlight: Research Points Way to Blood Test for Ovarian Cancer

New Blood Test Developed to Diagnose Ovarian Cancer

Detecting Radiation Exposure with a Blood Test. Scientific American, May 16, 2017

Katherine Choe, Ph.D.  joins the lab as a post-doctoral fellow

Yizhou He, Ph.D. awarded the AACR-AstraZeneca Ovarian Cancer Research Fellowship

Dr. Chowdhury Appointed Chief of the Division of Radiation and Cancer Biology at Dana-Farber 

Serum MicroRNA Signature Reflects Radiation Exposure, Lethality. Genome Web, Mar 07, 2017

Tina's Wish Benefit Raises $1.4M for Early Detection Ovarian Cancer Research at the American Museum of Natural History. PR Newswire, Sep 29, 2016

Novel cause of ovarian cancer drug resistance identified. Dana-Farber, January 07, 2016

Exposed to dangerous radiation? Telltale signs are in your blood. Science, May. 13, 2015

This Quick Genetic Test Could Predict a Person's Radiation Damage After a Disaster. Popular Mechanics, May 13, 2015

MicroRNA discovered to play role in DNA repair. Dana-Farber, April 19, 2010